MicroPort Affiliate Endovastec Reports 22% Drop in Nine-Month Net Profit
Reuters
Oct 29
MicroPort Affiliate Endovastec Reports 22% Drop in Nine-Month Net Profit
MicroPort Scientific Corporation announced unaudited financial results for its affiliate, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. ("Endovastec"), for the nine months ended 30 September 2025. MicroPort holds a 40.32% stake in Endovastec. Endovastec reported revenue of RMB 1,014.78 million, up 4.66% year-on-year, and net profit attributable to equity owners of RMB 429.06 million, down 22.46% from the prior year.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on October 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.